Notably, a significantly poorer survival rate was observed in PFS for those MM patients classified in MYC IV, MIR22HG I quartiles (Figure 1b, left), whereas no significant differences were observed between the two MYC–MIR22HG groups with respect to OS (data not shown). The gene discussed is MYC; the disease is Miyoshi myopathy.